Recombinant Human MR1 Protein，GST

MR1 (MHC class I-related molecule 1) is a non-classical major histocompatibility complex protein that plays a crucial role in the immune system, particularly in presenting vitamin B metabolites to MAIT (mucosal-associated invariant T) cells. These T cells are a unique subset of innate-like lymphocytes that bridge the innate and adaptive immune responses. MR1's primary function involves recognizing microbial-derived vitamin metabolites and initiating a rapid immune response, making it essential in the defense against various infections, especially those caused by bacteria. Given the rising interest in targeting MR1 for immunotherapies, researchers have been working to understand its structure, function, and the mechanisms by which it activates MAIT cells. Notably, MR1's ability to present antigens in a non-traditional manner distinguishes it from classical MHC molecules, thus opening new avenues for drug development and vaccine strategies. Furthermore, MR1 has been implicated in various diseases, including cancer and autoimmune disorders, suggesting that modulation of MR1 interactions may have therapeutic potential. The study of MR1 and its interactions not only enhances our understanding of immune evasion by pathogens but may also contribute to the development of novel immunotherapeutic approaches aimed at harnessing this unique immune pathway. As such, MR1 research stands at the forefront of immunology, with significant implications for improving human health through innovative therapies leveraging the immune system's mechanisms.